SAM
KIN
Silverback Asset Management’s Kindred Biosciences, Inc. KIN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-300,000
| Closed | -$2.75M | – | 88 |
|
|
2021
Q2 | $2.75M | Sell |
300,000
-284,653
| -49% | -$2.61M | 0.33% | 56 |
|
|
2021
Q1 | $2.91M | Sell |
584,653
-26,711
| -4% | -$133K | 0.63% | 36 |
|
|
2020
Q4 | $2.64M | Buy |
611,364
+20,819
| +4% | +$89.7K | 0.33% | 49 |
|
|
2020
Q3 | $2.53M | Buy |
590,545
+9,377
| +2% | +$40.2K | 0.53% | 45 |
|
|
2020
Q2 | $2.61M | Buy |
581,168
+54,180
| +10% | +$243K | 0.65% | 41 |
|
|
2020
Q1 | $2.11M | Sell |
526,988
-13,690
| -3% | -$54.8K | 0.45% | 38 |
|
|
2019
Q4 | $4.59M | Hold |
540,678
| – | – | 0.68% | 26 |
|
|
2019
Q3 | $3.7K | Buy |
540,678
+31,181
| +6% | +$214 | 0.57% | 35 |
|
|
2019
Q2 | $4.24M | Buy |
509,497
+9,497
| +2% | +$79.1K | 0.65% | 33 |
|
|
2019
Q1 | $4.59M | Buy |
500,000
+216,809
| +77% | +$1.99M | 0.78% | 29 |
|
|
2018
Q4 | $3.1M | Buy |
283,191
+134,791
| +91% | +$1.48M | 0.57% | 33 |
|
|
2018
Q3 | $2.07M | Buy |
+148,400
| New | +$2.07M | 0.32% | 37 |
|